Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients
Crossref DOI link: https://doi.org/10.1186/1939-4551-8-S1-A75
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nayci, Sibel
Ozgur, Eylem
Ozge, Cengiz
Text and Data Mining valid from 2015-01-01
Version of Record valid from 2019-07-26
License valid from 2015-01-01